Salto-Tellez M - Search Results

1

RUNX3 acts as a tumor suppressor in breast cancer by targeting estrogen receptor α.

Huang B, Qu Z, Ong CW, Tsang YH, Xiao G, Shapiro D, Salto-Tellez M, Ito K, Ito Y, Chen LF. Huang B, et al. Oncogene. 2012 Jan 26;31(4):527-34. doi: 10.1038/onc.2011.252. Epub 2011 Jun 27. Oncogene. 2012. PMID: 21706051 Free PMC article.

2

RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization.

Ito K, Liu Q, Salto-Tellez M, Yano T, Tada K, Ida H, Huang C, Shah N, Inoue M, Rajnakova A, Hiong KC, Peh BK, Han HC, Ito T, Teh M, Yeoh KG, Ito Y. Ito K, et al. Cancer Res. 2005 Sep 1;65(17):7743-50. doi: 10.1158/0008-5472.CAN-05-0743. Cancer Res. 2005. PMID: 16140942

3

RUNX3 protein is overexpressed in human basal cell carcinomas.

Salto-Tellez M, Peh BK, Ito K, Tan SH, Chong PY, Han HC, Tada K, Ong WY, Soong R, Voon DC, Ito Y. Salto-Tellez M, et al. Oncogene. 2006 Dec 7;25(58):7646-9. doi: 10.1038/sj.onc.1209739. Epub 2006 Jun 12. Oncogene. 2006. PMID: 16767156

4

RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer.

Lau QC, Raja E, Salto-Tellez M, Liu Q, Ito K, Inoue M, Putti TC, Loh M, Ko TK, Huang C, Bhalla KN, Zhu T, Ito Y, Sukumar S. Lau QC, et al. Cancer Res. 2006 Jul 1;66(13):6512-20. doi: 10.1158/0008-5472.CAN-06-0369. Cancer Res. 2006. PMID: 16818622

5

Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.

Chen W, Salto-Tellez M, Palanisamy N, Ganesan K, Hou Q, Tan LK, Sii LH, Ito K, Tan B, Wu J, Tay A, Tan KC, Ang E, Tan BK, Tan PH, Ito Y, Tan P. Chen W, et al. Genes Chromosomes Cancer. 2007 Mar;46(3):288-301. doi: 10.1002/gcc.20411. Genes Chromosomes Cancer. 2007. PMID: 17171680

6

RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.

Subramaniam MM, Chan JY, Soong R, Ito K, Ito Y, Yeoh KG, Salto-Tellez M, Putti TC. Subramaniam MM, et al. Breast Cancer Res Treat. 2009 Jan;113(1):113-21. doi: 10.1007/s10549-008-9917-4. Epub 2008 Feb 7. Breast Cancer Res Treat. 2009. PMID: 18256927

7

RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.

Ito K, Lim AC, Salto-Tellez M, Motoda L, Osato M, Chuang LS, Lee CW, Voon DC, Koo JK, Wang H, Fukamachi H, Ito Y. Ito K, et al. Cancer Cell. 2008 Sep 9;14(3):226-37. doi: 10.1016/j.ccr.2008.08.004. Cancer Cell. 2008. PMID: 18772112 Free article.

8

RUNX3 inactivation in colorectal polyps arising through different pathways of colonic carcinogenesis.

Subramaniam MM, Chan JY, Soong R, Ito K, Yeoh KG, Wong R, Guenther T, Will O, Chen CL, Kumarasinghe MP, Ito Y, Salto-Tellez M. Subramaniam MM, et al. Am J Gastroenterol. 2009 Feb;104(2):426-36. doi: 10.1038/ajg.2008.141. Epub 2009 Jan 27. Am J Gastroenterol. 2009. PMID: 19174785

9

The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome.

Soong R, Shah N, Peh BK, Chong PY, Ng SS, Zeps N, Joseph D, Salto-Tellez M, Iacopetta B, Ito Y. Soong R, et al. Br J Cancer. 2009 Mar 10;100(5):676-9. doi: 10.1038/sj.bjc.6604899. Epub 2009 Feb 17. Br J Cancer. 2009. PMID: 19223906 Free PMC article.

10

Molecular pathology of RUNX3 in human carcinogenesis.

Subramaniam MM, Chan JY, Yeoh KG, Quek T, Ito K, Salto-Tellez M. Subramaniam MM, et al. Biochim Biophys Acta. 2009 Dec;1796(2):315-31. doi: 10.1016/j.bbcan.2009.07.004. Epub 2009 Aug 12. Biochim Biophys Acta. 2009. PMID: 19682550 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters